As of 2024-07-27, the Relative Valuation of Ligand Pharmaceuticals Inc (LGND) is 116.32 USD. This relative valuation is based on P/E multiples. With the latest stock price at 107.14 USD, the upside of Ligand Pharmaceuticals Inc based on Relative Valuation is 8.6%.
The range of the Relative Valuation is 61.17 - 204.71 USD.
| Range | Selected | |
| Trailing P/E multiples | 31.4x - 38.2x | 31.8x |
| Forward P/E multiples | 30.8x - 39.4x | 31.2x |
| Fair Price | 61.17 - 204.71 | 116.32 |
| Upside | -42.9% - 91.1% | 8.6% |
| Date | P/E |
| 2024-07-26 | 19.97 |
| 2024-07-25 | 19.76 |
| 2024-07-24 | 19.19 |
| 2024-07-23 | 19.08 |
| 2024-07-22 | 18.91 |
| 2024-07-19 | 18.60 |
| 2024-07-18 | 18.45 |
| 2024-07-17 | 18.84 |
| 2024-07-16 | 18.45 |
| 2024-07-15 | 18.02 |
| 2024-07-12 | 18.53 |
| 2024-07-11 | 18.27 |
| 2024-07-10 | 17.95 |
| 2024-07-09 | 17.10 |
| 2024-07-08 | 16.20 |
| 2024-07-05 | 15.73 |
| 2024-07-03 | 15.42 |
| 2024-07-02 | 15.81 |
| 2024-07-01 | 15.82 |
| 2024-06-28 | 15.71 |
| 2024-06-27 | 15.35 |
| 2024-06-26 | 14.51 |
| 2024-06-25 | 14.71 |
| 2024-06-24 | 14.91 |
| 2024-06-21 | 14.80 |
| 2024-06-20 | 14.88 |
| 2024-06-18 | 15.01 |
| 2024-06-17 | 15.03 |
| 2024-06-14 | 14.92 |
| 2024-06-13 | 15.16 |
| 2024-06-12 | 14.94 |
| 2024-06-11 | 14.93 |
| 2024-06-10 | 14.83 |
| 2024-06-07 | 15.17 |
| 2024-06-06 | 15.35 |
| 2024-06-05 | 15.58 |
| 2024-06-04 | 15.07 |
| 2024-06-03 | 16.39 |
| 2024-05-31 | 15.85 |
| 2024-05-30 | 15.65 |
| 2024-05-29 | 15.84 |
| 2024-05-28 | 16.03 |
| 2024-05-24 | 16.11 |
| 2024-05-23 | 15.83 |
| 2024-05-22 | 16.27 |
| 2024-05-21 | 16.22 |
| 2024-05-20 | 16.15 |
| 2024-05-17 | 16.04 |
| 2024-05-16 | 15.85 |
| 2024-05-15 | 15.99 |